25I-NB34MD

25I-NB34MD
Clinical data
Other names	NB34MD-2C-I
ATC code	None;
Legal status
Legal status	UK: Class A;
Identifiers
	IUPAC name N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine;
CAS Number	1391497-81-6 ;
ChemSpider	58191429 ;
UNII	R7X848UW5A;
Chemical and physical data
Formula	C18H20INO4
Molar mass	441.265 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O1C2=C(OC1)C=C(C=C2)CNCCC3=C(C=C(C(=C3)OC)I)OC;
	InChI InChI=1S/C18H20INO4/c1-21-16-9-14(19)17(22-2)8-13(16)5-6-20-10-12-3-4-15-18(7-12)24-11-23-15/h3-4,7-9,20H,5-6,10-11H2,1-2H3 ; Key:FWEBGKDUEZRMRQ-UHFFFAOYSA-N ;

25I-NB34MD (NB34MD-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a potent partial agonist for the human 5-HT_2A receptor, and presumably has similar properties to 2C-I.^[1] It has a binding affinity of 0.67nM at the human 5-HT_2A receptor, making it several times weaker than its positional isomer 25I-NBMD and a similar potency to 25I-NBF.^[2]^[3]